Capacity Bio

Endurance Bio

This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.

Vandria

This biopharmaceutical company develops small molecule mitophagy inducers to treat patients with age-related and chronic diseases, specifically targeting neurodegenerative and muscle disorders.

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

MitoImmune Therapeutics

This biotechnology firm develops mitochondrial-targeted therapies for patients with inflammatory and rare diseases, including cancer treatment side effects like oral mucositis.

Nilo Therapeuti

This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.

Paeanbio

The company develops mitochondria-based biopharmaceuticals and cell therapies to treat inflammatory, autoimmune and oncology patients.

Velgene

This company develops small molecules that stimulate autophagic pathways to treat neurodegenerative diseases and cancer for the global pharmaceutical and biotechnology industries.

Cadenza Bio

This biotechnology company develops small-molecule drugs to treat demyelinating and inflammatory diseases, such as multiple sclerosis and endometriosis, for patients and healthcare providers.